🔎 Trials Near Me

ホーム › 高血圧 › テキサス

テキサスにおける高血圧の臨床試験

テキサス内の拠点で、高血圧に関する27件の研究が参加者を募集しています。

テキサス内の都市

公式研究テキスト(英語)

A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension

  • Retension Clinical Site, Bellaire
  • Retension Clinical Site, Dallas
  • Retension Clincal Site, Plano
  • 他2件
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/10/02更新 · NCT07142356

BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT

  • Baylor Scott & White Research Institute, Dallas
被験者募集中
18歳以上 · 全性別 · 2026/10/02更新 · NCT06059638

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

  • Horizon Clinical Research Group, Cypress
  • Cardiovascular Specialists of Willowbrook, Houston
  • Texas Cardiology Associates of Houston, Kingwood
  • 他2件
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07783802

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  • Pinnacle Clinical Research - Austin, Austin
  • South Texas Research Institute - Brownsville, Brownsville
  • Headlands Research - Brownsville, Brownsville
  • 他25件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07064473

Study of Efficacy and Safety of Tonlamarsen in Participants With a Recent Hospitalization and a Concurrent Episode of Acute Severe Hypertension

  • Laguna Clinical Research Associates, Laredo
  • Tapia Internal Medicine Clinic, Paris
  • Baylor Scott and White Research Institute - Temple, Temple
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07511361

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

  • IMA Clinical Research Austin, Austin
  • Headlands Horizons, LLC dba Headlands Research-Brownsville, Brownsville
  • Cedar Health Research - Texas Native Health, Dallas
  • 他10件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07794579

A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

  • Research Site, Arlington
  • Research Site, Austin
  • Research Site, Austin
  • 他8件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06742723

THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension

  • Plaza Medical Center of Fort Worth, Fort Worth
  • Houston Medical Center, Houston
被験者募集中
22歳〜75歳 · 全性別 · 2026/09/24更新 · NCT06559891

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

  • Clinical Trial Site, Allen
  • Clinical Trial Site, Amarillo
  • Clinical Trial Site, Amarillo
  • 他43件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/18更新 · NCT07181109

Sympathetic Transduction in Obesity-associated Hypertension (OB-HTN)

  • University of Texas Southwestern Medical Center, Dallas
被験者募集中早期第1相健康なボランティア歓迎
18歳〜55歳 · 全性別 · 2026/09/03更新 · NCT04838678

IMPACT: Improving Maternal Postpartum Access to Care Through Telemedicine

  • Parkland Hospital, Dallas
被験者募集中健康なボランティア歓迎
18歳以上 · 女性 · 2026/09/02更新 · NCT06218355

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

  • Dell Children's Medical Center of Central Texas, Austin
被験者募集中観察研究健康なボランティア歓迎
0歳〜20歳 · 全性別 · 2026/08/21更新 · NCT04278404

Global Paradise System US Post Approval Study

  • Ascension Seton, Austin
  • Dallas VAMC, Dallas
  • TCR Institute, Kingwood
被験者募集中観察研究
18歳以上 · 全性別 · 2026/08/12更新 · NCT06297291

Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage

  • UT Southwestern Medical Center, Dallas
  • University of Texas Health Science Center San Antonio, San Antonio
被験者募集中観察研究
18歳〜100歳 · 全性別 · 2026/08/07更新 · NCT06402968

Polypill for Prevention of Cardiomyopathy

  • UT Southwestern Medical Center, Dallas
被験者募集中第1/2相
18歳〜100歳 · 全性別 · 2026/08/04更新 · NCT06143566

A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia

  • Synergy Group Medical LLC, Houston
  • Synergy Group Medical LLC, Houston
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/07/30更新 · NCT07610278

An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.

  • Sun Research Institute, San Antonio
被験者募集中第2相
18歳以上 · 全性別 · 2026/07/30更新 · NCT07543120

A Pivotal Study to Evaluate the Effectiveness of Isometric Handgrip Therapy in Elevated Blood Pressure and Hypertensive Subjects

  • Zenos Clinical Research, Dallas
  • Aavon Clinical Trials, Houston
被験者募集中
22歳以上 · 全性別 · 2026/07/24更新 · NCT06843577

Blood Pressure Slopes and Ultrafiltration in Hemodialysis Patients

  • VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX, Dallas
被験者募集中
18歳以上 · 全性別 · 2026/07/20更新 · NCT04163614

SPYRAL GEMINI Pilot Study

  • Baylor Heart & Vascular Hospital, Dallas
  • UT Health East Texas, Tyler
被験者募集中
18歳〜80歳 · 全性別 · 2026/06/24更新 · NCT06907147

Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults

  • University of Texas Medical Branch, Galveston
被験者募集中
18歳以上 · 全性別 · 2026/05/18更新 · NCT05955339

PRESSURE CHECK: Find Your Path to Better Health

  • Houston Methodist, Houston
被験者募集中
18歳以上 · 全性別 · 2026/03/24更新 · NCT06122246

Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension

  • Vanda Investigative Site, Carrollton
被験者募集中第2相
18歳〜65歳 · 全性別 · 2026/02/27更新 · NCT07090161

Assessing the Efficacy of Targeted Home Visits in the Management of Chronic Conditions

  • UT Southwestern Medical Center, Dallas
被験者募集中
18歳〜60歳 · 全性別 · 2026/02/10更新 · NCT05168605

Preventing Cognitive Decline by Reducing BP Target Trial

  • UT Southwestern Medical Center, Dallas
被験者募集中
70歳以上 · 全性別 · 2025/12/03更新 · NCT05106036

Targeting Endoplasmic Reticulum Stress in Human Hypertension

  • University of North Texas Health Science Center, Fort Worth
被験者募集中第1/2相
18歳〜80歳 · 全性別 · 2025/03/28更新 · NCT06025630

ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。